Cover Image
市場調查報告書

衣索比亞的醫藥品市場分析

Analysis of the Ethiopian Pharmaceutical Market

出版商 Frost & Sullivan 商品編碼 351226
出版日期 內容資訊 英文 77 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
衣索比亞的醫藥品市場分析 Analysis of the Ethiopian Pharmaceutical Market
出版日期: 2016年01月29日 內容資訊: 英文 77 Pages
簡介

本報告提供衣索比亞的醫藥品市場相關調查,衣索比亞概要,基礎設施、經濟狀況,醫療產業和醫療基礎設施,疾病簡介,醫藥品市場與採購、流通流程,競爭環境與新的市場機會,醫藥品市場整體收益的變化與預測,處方藥、非處方藥、學名藥、品牌藥等各種類趨勢,以及主要企業的簡介等彙整。

第1章 摘要整理

  • 主要調查結果
  • 調查範圍、調查區分
  • 主要課題
  • 測量值
  • CEO的展望
  • 關注的企業
  • 三大預測

第2章 市場概要

  • 關於衣索比亞
  • 基礎設施、經濟狀況
  • 醫療產業
  • 醫療基礎設施
  • 疾病簡介
  • 醫療財政指標
  • 醫藥品市場:背景
  • 採購、流通流程
  • 醫藥品登記的必要條件
  • 醫藥品市場:市場區隔
  • 學名藥的佔有率擴大
  • 醫藥品市場:市場區隔
  • FEAPM (Federation of East African Pharmaceutical Manufacturers)

第3章 競爭環境

  • 新的市場機會
  • M&A、聯盟的評估

第4章 成長推進因素、阻礙要素、趨勢:整體市場

  • 市場促進因素
  • 市場成長的阻礙要素

第5章 預測、趨勢:整體市場

  • 測量值
  • 預測的前提條件、定義
  • 收益預測:市場規模
  • 非處方藥、學名藥、品牌藥的收益佔有率預測
  • 收益預測相關討論
  • 主要治療區分的成長分析
  • 主要治療區分的成長預測
  • 整體市場大環境分析

第6章 競爭環境

  • 市場佔有率:處方藥、非處方藥
  • 市場佔有率:學名藥
  • 市場佔有率:品牌藥

第7章 關注的企業

  • Addis Pharmaceutical Factory PLC
  • Aurobindo Pharma Limited
  • Cadila Pharmaceutical Limited
  • GlaxoSmithKline PLC
  • Julphar (Gulf Pharmaceutical Industries)
  • Novartis International AG

第8章 總論

  • 三大預測
  • 討論
  • 免責聲明

第9章 附錄

目錄
Product Code: MB49-01-00-00-00

Market Position of Prescription and Over-the-counter Drugs

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and transformation plan, and so on), key participants in the market, population and disease statistics, and so on. The study also describes the opportunities and constraints in the market and revenue forecasts for the total market from 2011-2020. Primary research interviews with industry stakeholders and secondary research through in-house Frost & Sullivan database and news reports were undertaken.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Scope and Segmentation
  • 3. Key Questions this Study will Answer
  • 4. Measurements
  • 5. CEO's Perspective
  • 6. Key Companies to Watch
  • 7. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. About Ethiopia
  • 2. Infrastructure and Economic Situation
  • 3. Healthcare Industry
  • 4. Healthcare Infrastructure
  • 5. Disease Profile
  • 6. Healthcare Financing Indicators
  • 7. Pharmaceutical Market-Background
  • 8. Process of Procurement and Distribution
  • 9. Essential Requirements for Drug Registration
  • 10. Total Pharmaceutical Market-Segmentation
  • 11. Increase in Generic Drugs' Market Share
  • 12. Total Pharmaceutical Market-Segmentation
  • 13. Federation of East African Pharmaceutical Manufacturers

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. Merger, Acquisition, and Partnership Assessment

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL PHARMACEUTICAL MARKET

Drivers, Restraints, and Trends-Total Pharmaceutical Market

  • 1. Market Drivers
  • 2. Market Drivers (continued)
  • 3. Market Restraints

5. FORECAST AND TRENDS-TOTAL PHARMACEUTICAL MARKET

Forecast and Trends-Total Pharmaceutical Market

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast by Market Size
  • 4. Per Cent Revenue Forecast by Nonprescription, Generic, and Branded Drugs
  • 5. Revenue Forecast Discussion
  • 6. Growth Analysis of Key Therapeutic Segments
  • 7. Growth Forecast of Key Therapeutic Segments
  • 8. Total Pharmaceutical Market-PESTLE Analysis

6. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. Market Share-Prescription Drugs and Nonprescription Drugs
  • 2. Market Share-Generic Drugs
  • 3. Market Share-Branded Drugs

7. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Companies to Watch
  • 2. Companies to Watch (continued)
  • 3. Addis Pharmaceutical Factory PLC
  • 4. Aurobindo Pharma Limited
  • 5. Cadila Pharmaceutical Limited
  • 6. GlaxoSmithKline PLC
  • 7. Julphar (Gulf Pharmaceutical Industries)
  • 8. Novartis International AG

8. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. The Last Word-Discussion (continued)
  • 5. Legal Disclaimer

9. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Drivers Explained (continued)
  • 6. Restraints Explained
  • 7. Restraints Explained (continued)
  • 8. Restraints Explained (continued)
  • 9. List of Companies in “Others”
  • 10. List of Companies in “Others” (continued)
  • 11. Methodology
  • 12. Learn More-Next Steps
  • 13. List of Exhibits
  • 14. List of Exhibits (continued)
  • 15. List of Exhibits (continued)

List of Exhibits

  • Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
  • Population Split by Gender, Ethiopia, 2014
  • Inflation at Consumer Prices, Ethiopia, 2010-2014
  • Annual Infrastructural Improvements, Ethiopia, 2011-2015
  • Healthcare Statistics, Ethiopia, 2011 and 2013
  • Structure of Public Healthcare in Ethiopia
  • Per cent of Health Facilities, Ethiopia, 2012
  • Total Number of Hospitals by Region, Ethiopia, 2012
  • Top Causes of Deaths, Ethiopia, 2012
  • Disease Indicators, Ethiopia, 2011 and 2013
  • Healthcare Expenditures, Ethiopia, 2010-2013
  • Per cent of Imported Drugs Versus Locally Manufactured Drugs, Ethiopia. 2014
  • Total Pharmaceutical Market: Procurement Process, Ethiopia, 2014
  • Total Pharmaceutical Market: Market Segmentation, Ethiopia, 2014
  • Total Pharmaceutical Market: Per cent Sales Breakdown by Therapeutic Segment, Ethiopia, 2014
  • Members of the Ethiopian Pharmaceuticals and Medical Supplies Manufacturing Industries Association
  • Total Pharmaceutical Market: Game-changing Strategies, Ethiopia, 2014
  • Total Pharmaceutical Market: Market Outlook, Ethiopia, 2011-2014
  • Total Pharmaceutical Market: Key Market Drivers, Ethiopia, 2015-2020
  • Total Pharmaceutical Market: Key Market Restraints, Ethiopia, 2015-2020
  • Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
  • Total Pharmaceutical Market: Revenue Forecast, Ethiopia, 2011-2020
  • Total Pharmaceutical Market: Per cent Revenue Forecast by Nonprescription, Generic and Branded Drugs, Ethiopia, 2011-2020
  • Total Pharmaceutical Market: Therapeutic Segment Growth Analysis, Ethiopia, 2015-2020
  • Total Pharmaceutical Market: Growth Forecast by Therapeutic Segments, Ethiopia, 2014
  • Total Pharmaceutical Market: PESTLE Analysis, Ethiopia, 2014
  • Total Pharmaceutical Market: Per Cent Revenue Breakdown, Ethiopia, 2014
  • Generic Drugs Segment: Per Cent Revenue Breakdown, Ethiopia, 2014
  • Branded Drugs Segment: Per Cent Revenue Breakdown, Ethiopia, 2014
  • GDP Per Capita, Ethiopia, 2010-2014
  • Health Financing Sources, Ethiopia, 2013
  • Historical and Projected Population, Ethiopia, 2009-2020
Back to Top